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OBJECTIVES: To carry out a retrospective complete histomorphological study with 
survival analyses and BRAF mutation status of primary cutaneous and anal 
melanoma. 
METHODS: A cohort study was conducted on primary cutaneous and anal 
melanomas (January 2013 to December 2015) wherein a complete histomorphological 
study, in accordance with AJCC (2010)  pathological staging criteria along with 
clinicopathological correlation and BRAF
 V600E
 mutation analysis by polymerase chain 
reaction was carried out.AJCC (2010) classification for cutaneous melanomas were 
applied to anal melanomas as they did not have any standard pathological staging 
criteria.  
RESULTS: There were 39 cutaneous and 11 anal melanomas, both displaying earlier 
age at presentation (median: 51.5 years) and male preponderance. The most common 
invasive subtypes were acrallentiginous (cutaneous) and nodular (anal). Anal 
melanomas presented as thicker tumours (median: 7.8 mm). Presence of ulceration 
(88%), lymphovascular invasion (70%), perineural invasion (42%), satellite/in transit 
metastases (28%) and regression (16%) were noted. Six (42.9%) of 11 patients with 
nodal metastases displayed extracapsular extension. Metastases developed in 23 
(46%) patients, the most common site being liver; five patients developed clinical 
recurrence. Majority of tumours were of stage T3&T4 (94%), N2&N3 (42%) and M1c 
(38%). Anal melanomas showed higher rates of recurrence and metastases with the 
propensity to develop metastases in multiple sites, especially on presentation. 
Increased frequency of metastases on diagnosis is associated with nodular melanomas 
(both anal and cutaneous) and melanomas exhibiting  regression. Anal melanomas 
presented with thicker and ulcerated tumours and showed 2.4 times higher risk (95% 
CI: 1.4-4.1) for development of metastases as compared to cutaneous 
melanomas.Acrallentiginous melanomas were associated with elevated levels of 
serum LDH as compared to nodular melanomas which showed no difference in the 
serum LDH levels.Extranodal extension of tumour was associated with the presence 
of distant metastases.  
The 1-year, 2-year and 3-year overall survival (OS) rates of all melanomas 
were77.8%, 22.2% and 5.6% respectively with a median OS of 16 months (95% CI: 
14-35 months). Lesser OS was significantly associated with medium cell size and 
involved peripheral margin of invasive component. The 1-year, 2-year and 3-year 
distant metastases free survival (DMFS) rates were 64.3%, 28.6% and 14.3% 
respectively (median: 25 months, 95% CI: 8-36 months). Presence of satellitosis and 
in transit metastases had a significant negative impact on the distant metastases free 
survival. At the end of one year, 40% patients were found to be free of recurrence 
(mean: 29.8 months, 95% CI: 22.5-37.1 months).  Factors associated with poor 
prognosis included gender (females), ulceration, increased Clark level, vertical growth 
phase, absence of tumour infiltrating lymphocytes, increased mitotic rate (> 12/mm
2
), 
amelanotictumours, involved margins, larger metastatic nodal size (> 6cm), elevated 
levels of serum LDH and advanced stage. These findings were not statistically 
significant. 
There was complete absence of BRAF
V600E
 mutation in all the amplifiable cases 
(n=45), with an estimated probable prevalence of 2.7% in our population. Increased 
nest formation and upward scatter, larger pigmented cells with epithelioid morphology 
and continuous lateral circumscription were associated with absent BRAF
V600E
 
mutation in our population. 
CONCLUSIONS: Primary melanomas, both cutaneous and anal, show earlier age at 
presentation as compared to Caucasian population. Acrallentiginous melanoma is the 
most common subtype, unlike Caucasians who have predominance of superficial 
spreading melanoma. Anal melanomas display higher recurrence and metastases rate, 
especially on presentation involving multiple sites, similar to global studies. 
Significant adverse prognostic factors for overall survival include medium cell size 
and involved peripheral margins. Presence of satellite/in transit metastases is 
significantly associated with increased metastases and reduced survival. Female 
gender and amelanotic tumours tend to have poor overall prognosis. Complete 
absence of BRAF
V600E
 mutation in all the amplifiable cases, with an estimated 
probable prevalence of 2.7% in our population shows that the actual prevalence of 
BRAF
V600E
 mutation in the Indian population is much lower than that described in 
Asian literature. Increased nest formation and upward scatter, larger pigmented cells 
with epithelioid morphology and continuous lateral circumscription are associated 
with absent BRAF
V600E
 mutation in our population. 
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